Imidapril HCl
CAS No. 89396-94-1
Imidapril HCl( TA-6366 )
Catalog No. M19235 CAS No. 89396-94-1
Imidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 48 | In Stock |
|
| 25MG | 86 | In Stock |
|
| 50MG | 147 | In Stock |
|
| 100MG | 219 | In Stock |
|
| 200MG | 326 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameImidapril HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionImidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.
-
DescriptionImidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.
-
In Vitro——
-
In Vivo——
-
SynonymsTA-6366
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorACE
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number89396-94-1
-
Formula Weight441.91
-
Molecular FormulaC20H27N3O6·HCl
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 113.15 mM; H2O : 50 mg/mL 113.15 mM
-
SMILESCCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@@H](CN(C2=O)C)C(=O)O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
BW 245C
BW 245C is a selective prostaglandin-like DP receptor (DP1) agonist, a prostaglandin analogue with inhibitory effects on the aggregation response of collagen, which can be used to study diseases such as stroke.
-
DG-041
DG-041 is an antagonist of high affinity EP3 receptor (IC50s: 4.6 nM and 8.1 nM in the binding and FLIPR assay, respectively ).
-
Carboprost trometham...
Carboprost tromethamine is the synthetic 15-methyl analogue of prostaglandin F2α and it can effectively promote law contraction of the uterus and significantly reduce the amount of bleeding during and after delivery.Carboprost tromethamine has been accounted for to be 84-96% successful in the treatment of persistent hemorrhage because of uterine atony.
Cart
sales@molnova.com